The natural ingredients in TGA-certified REGENAPEP inactivate a multi-dimensional cascade of inflammatory process, primarily through the blockage of interleukin 1 receptors and inhibition of other pro-inflammatory cytokines, to relieve pain and offer lasting musculoskeletal protection.

REGENAPEP’s colostrum is enriched and purified with interleukin-1 receptor antagonist peptides (IL1RA). IL1RA peptide is a fast-acting agent that may effectively counteract and suppress pro-inflammatory cytokines to relief musculoskeletal, rheumatic and arthritic pain, and to prevent, delay or manage the progression of inflammatory diseases.

The fortification of REGENAPEP’s formula with a combination of purified botanical ingredients (proven to engender specific anti-inflammatory qualities) may address the multiple pathways of systemic inflammation commonly observed in arthritis and musculoskeletal conditions.

This includes the blockage of interleukin-1 receptors (colostrum), inhibition of NF-kB (curcuma longa, harpagophytum procumbens), prostaglandin E2 (curcuma longa, zingiber officinale), selective COX-2 (curcuma longa, harpagophytum procumbens), interleukin-6 (salix alba), TNF–α (salix alba), 5-lipoxygenase (boswellia serrata) and other inflammatory cytokines.

Contrary to the majority of over-the-counter oral supplements for joint health offered today, REGENAPEP’s IL1RA peptide (formulated as natural colostrum derivatives) and purified botanical ingredients not only relieve pain but also engender chondroprotective qualities. The ingredients may delay and reduce inflammatory degradation of articular cartilage, ultimately slowing down the deterioration of inflammatory-linked musculoskeletal and joint diseases, which may otherwise lead to expensive, highly invasive and risky surgical procedures (arthroplasty).

Suppressing the body’s systemic inflammation may lead to better regenerative conditions in the synovium and articular cartilage, ultimately promoting the natural repair-mechanism of joints for long-term relief. Curcuma longa and salix alba (REGENAPEP’s botanical ingredients) are capable of stimulating bone formation through osteoblast cell differentiation. Key trace minerals such as manganese sulphate in REGENAPEP is needed to build cartilage and maintain a normal skeletal growth.

REGENAPEP’s colostrum contains natural interleukin-1 receptor antagonist (IL1RA) peptides that are enriched and purified into concentrated amount of active derivatives using a unique and patent-pending ‘selective peptide purification and enrichment technology’. This represents a technological milestone for the industry, as no others are able to derive natural IL1RA peptides in a scalable production format.

REGENAPEP’s developer Dr. Bill V. P. has transformed the once bioengineered-only IL1RA peptides into a natural and accessible oral dietary supplement that is unique in comparison to the largely synthetic and drug-grade IL1RA injections or NSAIDs available in the market. REGENAPEP is all natural. It contains no drugs, steroids, chemicals and any other unpermitted substances.

REGENAPEP has regulatory certification from Therapeutic Goods Administration (TGA) in one of the most highly regulated markets in the world, Australia. This regulatory certification represents a validation of REGENAPEP’s safety and efficacy.

Colostrum is a well-researched therapeutic ingredient that has been certified by regulatory boards in most countries. Colostrum is also the selected source from which natural IL1RA peptides are derived. The combination with purified botanical ingredients that have an existing archive of recognised scientific research calls for easy product registration for REGENAPEP in most markets and enhanced accessibility for consumers globally.